JETEMA, Co., Ltd. (KOSDAQ:216080)
South Korea · Delayed Price · Currency is KRW 7,360.00
+220.00 (3.08%)
Apr 10, 2026, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 273.86 billion as of April 10, 2026. Its market cap has increased by 11.05% in one year.
Market Cap
273.86B
Enterprise Value
385.95B
Revenue
76.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,360.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 273.86B, an increase of 112.12%. That is a compound annual growth rate of 12.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 265.67B | 20.56% |
| Dec 30, 2025 | 220.37B | -20.54% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 417.38B |
| Anterogen.Co.,Ltd. | 401.24B |
| BINEX | 348.73B |
| GC Cell | 343.37B |
| HLB Therapeutics | 271.52B |
| Bioneer | 262.23B |
| EASY BIO,Inc. | 245.14B |
| Genexine | 210.80B |